Autoimmune Diseases: all 672 studies
Page 5 of 7. Open to participants first (272), then studies with results posted, then the rest; newest registration first within each.
- Exploring Immunological Markers Associated With Mental Fatigue in Graves' DiseaseTerminatedNCT05678374
- A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus ErythematosusActive, not recruitingNCT05672576Phase 3
- Efficacy of Modification of Lifestyle in the Treatment of Ankylosing Spondylitis: a Pilot StudyCompletedNCT05666115Not applicable
- Therapies for Down Syndrome Regression DisorderCompletedNCT05662228Phase 2
- A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus ErythematosusActive, not recruitingNCT05648500Phase 3
- A Multi-Centre, Randomised, Controlled, Masked Phase 2 Study of the Safety and Efficacy of KIO-101 Ophthalmic Solution, Versus Vehicle Control in the Treatment of Dry Eye Disease in Patients With Autoimmune DiseaseTerminatedNCT05629364Phase 2
- A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus ErythematosusActive, not recruitingNCT05620407Phase 3
- A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)Active, not recruitingNCT05617677Phase 3
- Post-COVID-19 Monitoring in Routine Health Insurance Data With Focus on Autoimmune Diseases (POINTED-AD)CompletedNCT05606198
- Immunomodulatory Therapy in Women With Autoimmune Premature Ovarian InsufficiencyCompletedNCT05586737Phase 2
- To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDPTerminatedNCT05581199Phase 2
- Autologous Adoptive T Regulatory Cell Transfer in Autoimmune Diseases.Status unknownNCT05566977Phase 1
- An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1DTerminatedNCT05565248Phase 1
- Transition to Adulthood Through Coaching and Empowerment in RheumatologyCompletedNCT05545839Not applicable
- In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory DiseasesCompletedNCT05544448Not applicable
- Quantification and Characterization of Circulating Epithelial and Endothelial Cells in Gougerot-Sjögren Syndrome, Compared to Systemic SclerosisCompletedNCT05528809Not applicable
- Study to Assess Batoclimab in Participants With Active Thyroid Eye DiseaseCompletedNCT05524571Phase 3
- Extension Study to Assess Batoclimab in Participants With Thyroid Eye DiseaseTerminatedNCT05517447Phase 3
- Study to Assess Batoclimab in Participants With Active Thyroid Eye DiseaseCompletedNCT05517421Phase 3
- Natural History and Pathogenesis of Alopecia in Children and AdultsCompletedNCT05502796
- Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia GravisCompletedNCT05451212Phase 1
- Effect of Home Exercise Program on Various Parameters in Patients With Multiple SclerosisCompletedNCT05447143Not applicable
- Group Education Trial to Improve Transition for Parents of Adolescents With T1DCompletedNCT05445284Not applicable
- A Study to Evaluate the Safety, PK and PD of VIS171 in Participants (Healthy and With Autoimmune Disease)CompletedNCT05418101Phase 1
- Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen DeterminationStatus unknownNCT05414890
- Vagus Nerve Stimulation for Systemic Lupus ErythematousCompletedNCT05315739Not applicable
- Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune DiseasesStatus unknownNCT05239702Early Phase 1
- An Open-Label, FIH Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects With T1DCompletedNCT05210530Phase 1
- To Evaluate the Safety of Treating Rheumatologic and Metabolic Patients With Molecular Hydrogen Supplement.Status unknownNCT05196295Phase 1
- To Evaluate the Safety of Treating Autoimmune Diseases With Molecular Hydrogen SupplementStatus unknownNCT05116215Phase 1
- The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech RepublicCompletedNCT05098600
- A Natural History Study to Assess the Clinical Outcomes of Patients With Complement Factor I Deficiency-Mediated DiseaseTerminatedNCT05095623
- A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory SclerodermaStatus unknownNCT05085444Early Phase 1
- A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's SyndromeStatus unknownNCT05085431Early Phase 1
- A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune NephritisStatus unknownNCT05085418Early Phase 1
- Collection and Distribution of Biospecimens for Novel ResearchStatus unknownNCT05080907
- Safety and Efficacy of Intrathecal Rituximab in Patients With Multiple SclerosisStatus unknownNCT05078177Phase 1
- One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis.CompletedNCT05069714Phase 3
- PK of Meropenem in Patients on Plasma ExchangeStatus unknownNCT05042271
- HIV and Inflammatory or Autoimmune Disease: Rare Patients, Many Questions (MAIVIH)Status unknownNCT05036811
- A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Systemic Lupus ErythematosusStatus unknownNCT05030779Early Phase 1
- Identification of Factors Associated With the Occurrence of Severe Forms of COVID-19 Infection in Patients With Inflammatory Rheumatism or Autoimmune DiseasesStatus unknownNCT05026892
- A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 DiabetesTerminatedNCT05018585Phase 3
- Neuropathological Changes of the Intestinal Wall in Patients With Bowel Evacuation DisordersCompletedNCT05016700
- Predicting Medication Response for Autoimmune DiseaseTerminatedNCT04995783
- Safety and Efficacy Study of Human Umbilical Cord-Derived Mesenchymal Stem Cells(BC-U001) for Rheumatoid ArthritisActive, not recruitingNCT04971980Phase 1/2
- Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and InflammationCompletedNCT04902807
- A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)Active, not recruitingNCT04895696Phase 2
- Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for VitiligoCompletedNCT04872257Not applicable
- Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or BiologicsTerminatedNCT04870411
- Autoimmune Gastrointestinal Dysmotility: Symptoms, Pathogenesis and TreatmentTerminatedNCT04859829
- Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or NatalizumabCompletedNCT04837651
- Imaging Evaluation of Central Nervous Autoimmune DiseasesStatus unknownNCT04822623
- Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 PatientsCompletedNCT04818970Not applicable
- COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune DiseasesCompletedNCT04806113Phase 3
- Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune DiseaseCompletedNCT04805099
- Rheumatologic Adverse Events and Cancer ImmunotherapyStatus unknownNCT04791150Not applicable
- Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-upStatus unknownNCT04789993
- Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple SclerosisCompletedNCT04786821Not applicable
- Supplementation With B. Infantis for Mitigation of Type 1 Diabetes AutoimmunityActive, not recruitingNCT04769037Not applicable
- Power Training in Older Multiple Sclerosis PatientsStatus unknownNCT04762342Not applicable
- Effects of Low-Level Laser Therapy on Oxidative Stress LevelsCompletedNCT04754607Not applicable
- Hypnosis in Internal MedecineStatus unknownNCT04698824
- Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative ColitisCompletedNCT04691232Phase 1
- IA or PE - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune DiseasesCompletedNCT04687332Not applicable
- Immunomodulatory Effects of Subcutaneous Progesterone in Patients Affected by Autoimmune DiseasesCompletedNCT04665232
- Immuno-Oncology Database and BioregistryCompletedNCT04656873
- Gluten Reduction and Risk of Celiac DiseaseActive, not recruitingNCT04593888Not applicable
- The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From PracticeCompletedNCT04558203
- Mental Health Consequences of COVID19 Infection in the French RMD CohortTerminatedNCT04510467
- Central Vein Sign: a Diagnostic Biomarker in Multiple SclerosisCompletedNCT04495556
- Effects of Silica and Asbestos Fibres on the Efferocytosis Capacities of MacrophagesCompletedNCT04473742Not applicable
- GFAP Auto-immunity : a French Cohort StudyStatus unknownNCT04463550
- Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CSL730 in Healthy Adult SubjectsTerminatedNCT04446000Phase 1
- Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in EuropeStatus unknownNCT04397237
- Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare DiseasesCompletedNCT04353609
- Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune DiseaseCompletedNCT04345159
- Safety and Tolerability of GX-P1 in Healthy Male VolunteersCompletedNCT04298749Phase 1
- Acquired Chronic Erosive Gingivitis: Clinical Relevance of Papillary Gingival BiopsyCompletedNCT04293718
- A Study of the Efficacy and Safety of Rituximab in Participants With Systemic SclerosisCompletedNCT04274257Phase 2/3
- "Circulating Fetal DNA, Pregnancy And Immune Diseases"Status unknownNCT04155086Not applicable
- Efficacy of Individualized Rituximab in Maintaining Remission of Moderate and Severe Systemic Lupus ErythematosusStatus unknownNCT04127747Phase 4
- Withdraw Drug in Stable IgG4-Related DiseaseStatus unknownNCT04124861Not applicable
- Autoimmunity in Patients With GAD-Ab and Their RelativesStatus unknownNCT04104620
- Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris PatientsStatus unknownNCT04096222
- Documentation of the Safety and Effectiveness Profile of the IgG Immunoadsorber GLOBAFFIN® in Clinical RoutineCompletedNCT04078698Not applicable
- Autoimmune Diseases and Serum Autoantibodies in NCWS and IBS PatientsCompletedNCT04077840
- Regulation of Lipid Metabolism in Autoimmune Disease: Multiple SclerosisStatus unknownNCT04053374
- A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Health SubjectStatus unknownNCT04041544Phase 1
- RT-CGM in Young Adults at Risk of DKAStatus unknownNCT04039763Not applicable
- Predictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care UnitStatus unknownNCT04022655
- Personal Lifestyle Engine (PLX) - Personal Lifestyle Medicine Center (PLMC)CompletedNCT04007939
- Personalized Lifestyle Intervention for Improving Functional Health Outcomes Using N-of-1 Tent-Umbrella-Bucket DesignCompletedNCT04005456Not applicable
- Single and Multiple Dose Pharmacokinetics of BMS-986165 in a Randomized, Double-Blind, Placebo-Controlled Study in Healthy Chinese SubjectsCompletedNCT03956953Phase 1
- Objective Measurement Methods for Autoimmune Disease and Dry Eye SyndromeWithdrawnNCT03937271
- Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell LymphomaActive, not recruitingNCT03922724Phase 2
- Lymphocyte Sub-populations and Auto Immune DiseasesCompletedNCT03901664
- Diagnostic and Imaging Indicators of Immunocardiomyopathic PatientsStatus unknownNCT03885375
- Distribution of Biospecimens From Biorepositories/Biobanks for Research UseWithdrawnNCT03884400
- Patient-Reported AutoImmunity Secondary to Cancer immunothErapyActive, not recruitingNCT03849131Phase 4